Specialized proresolving lipid mediators in humans with the metabolic syndrome after n–3 fatty acids and aspirin - Barden, Anne E; Mas, Emilie; Croft, Kevin D; Phillips, Michael; Mori, Trevor A (The American journal of clinical nutrition, 2015)
Keywords: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal - metabolism; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Aspirin - therapeutic use; Chromatography; Combined Modality Therapy; Comparative analysis; Cyclooxygenase Inhibitors - therapeutic use; Dietary Supplements; Docosahexaenoic Acids - blood; Docosahexaenoic Acids - metabolism; Eicosapentaenoic Acid - analogs & derivatives; Eicosapentaenoic Acid - blood; Eicosapentaenoic Acid - metabolism; Fatty acids; Fatty Acids, Omega-3 - metabolism; Fatty Acids, Omega-3 - therapeutic use; Female; Fish Oils - metabolism; Fish Oils - therapeutic use; Humans; Immunity, Innate - drug effects; Male; Mass spectrometry; Metabolic Syndrome - diet therapy; Metabolic Syndrome - drug therapy; Metabolic Syndrome - immunology; Metabolic Syndrome - metabolism; Middle Aged; Plasma; Postmenopause; Tablets, Enteric-Coated; Western Australia; Young Adult; metabolic syndrome; aspirin; n–3 fatty acids; resolvins; protectins